LivaNova PLC 8-K Summary: 2026 Annual General Meeting
Business Context and Reporting Period
This Form 8-K reports on the results of LivaNova PLC's 2026 Annual General Meeting (AGM) held on June 10, 2026. The filing details the voting outcomes for ten proposals submitted to shareholders, including director elections, executive compensation, auditor ratification, and capital management authorities.
Key Financial Metrics
The filing text does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
All ten proposals presented at the AGM were adopted by shareholders. Key outcomes include:
- Director Elections: All 11 director nominees were elected. Votes against ranged from approximately 96,890 to 517,219 per director, with significant broker non-votes (1,836,468) recorded for each.
- Executive Compensation: The "Say on Pay" proposal received 49,311,078 votes for and 499,536 votes against.
- Auditor Ratification: PricewaterhouseCoopers LLP (PwC) was ratified as the independent registered public accounting firm for 2026 (U.S.) and re-appointed as the UK statutory auditor.
- Capital Management:
- Shareholders authorized the allotment of shares up to a nominal amount of £10,985,296.
- Shareholders approved the waiver of pre-emption rights for equity securities up to the same nominal amount (£10,985,296).
- Shareholders approved a share repurchase program allowing the purchase of up to 10% of total issued Ordinary Shares as of April 13, 2026.
- Financial Statements: The audited UK statutory accounts for the year ended December 31, 2025, were received and adopted.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors. The document serves as a record of the AGM proceedings and voting tallies.
Investor Verification Checklist
- Verify the total number of issued Ordinary Shares as of April 13, 2026, to calculate the maximum share count available for repurchase under the approved 10% authority.
- Review the definitive Proxy Statement (dated April 29, 2026) for detailed terms of the Share Repurchase Contracts referenced in Appendix A and B.
- Confirm the specific terms of the auditor remuneration resolution, as the authority to determine fees was granted to the directors and/or Audit and Compliance Committee.
- Check subsequent filings for the actual execution of the share repurchase program and any new share issuances under the pre-emption waiver.